Their "cost of sales" was $3.0 billion, which someone please correct me if I'm wrong, but I think includes manufacturing (but not sales/distribution). But this still means that profit was more than it's total R&D and manufacturing budget.
Their "cost of sales" was $3.0 billion, which someone please correct me if I'm wrong, but I think includes manufacturing (but not sales/distribution). But this still means that profit was more than it's total R&D and manufacturing budget.
To start the discussion, I found this analysis of global pharma industry profitability: https://www.ispor.org/docs/default-source/euro2023/poster-is... Note that only 55% of the pharma companies even made a profit; the other 45% lost money. And the average profit margin was around 20%. So even if pharma companies voluntarily relinquished all profits, drugs would only be 20% cheaper!
The fundamental issue is that drug development is simply expensive. When people get angry about pharma profits, they're barking up the wrong tree.
That's mostly because around 90% of all drugs fail clinical tests.